S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(2.16%) $83.11
Gas
(1.98%) $1.752
Gold
(1.50%) $2 245.90
Silver
(1.28%) $25.07
Platinum
(1.49%) $923.25
USD/EUR
(0.39%) $0.927
USD/NOK
(0.82%) $10.86
USD/GBP
(0.13%) $0.792
USD/RUB
(0.15%) $92.58

Realtime updates for Luye Pharma Group Ltd [2186.HK]

Exchange: HKSE Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated28 Mar 2024 @ 04:08

-3.87% HKD 2.73

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 04:08):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers and other solid tumors; and Xuezhikang, a lipid regulating drug for the treatment of hypercholesterolaemia...

Stats
Today's Volume 13.71M
Average Volume 9.62M
Market Cap 10.27B
EPS HKD0 ( 2023-08-29 )
Last Dividend HKD0.0600 ( 2020-06-29 )
Next Dividend HKD0 ( N/A )
P/E 19.50
ATR14 HKD0.00600 (0.22%)

Volume Correlation

Long: -0.17 (neutral)
Short: -0.33 (neutral)
Signal:(58.814) Neutral

Luye Pharma Group Ltd Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Luye Pharma Group Ltd Correlation - Currency/Commodity

The country flag -0.53
( weak negative )
The country flag -0.11
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.56
( weak )

Luye Pharma Group Ltd Financials

Annual 2022
Revenue: HKD5.98B
Gross Profit: HKD4.14B (69.22 %)
EPS: HKD0.170
Q2 2023
Revenue: HKD1.45B
Gross Profit: HKD971.68M (66.92 %)
EPS: HKD0.0203
Q1 2023
Revenue: HKD1.45B
Gross Profit: HKD971.68M (66.92 %)
EPS: HKD0.0203
Q4 2022
Revenue: HKD1.57B
Gross Profit: HKD1.05B (66.77 %)
EPS: HKD0.0442

Financial Reports:

No articles found.

Luye Pharma Group Ltd Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

Luye Pharma Group Ltd Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 7.51 - good (75.09%) | Divividend Growth Potential Score: 3.34 - No dividend growth expected in the near future
Information
First Dividend HKD0.0370 2016-10-04
Last Dividend HKD0.0600 2020-06-29
Next Dividend HKD0 N/A
Payout Date 2020-07-24
Next Payout Date N/A
# dividends 8 --
Total Paid Out HKD0.406 --
Avg. Dividend % Per Year 0.00% --
Score 2.71 --
Div. Sustainability Score 7.51
Div.Growth Potential Score 3.34
Div. Directional Score 5.42 --
Next Divdend (Est)
(2024-08-02)
HKD0 Estimate 0.00 %
Dividend Stability
0.06 Very Bad
Dividend Score
2.71
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Warning: Undefined variable $stockPricesArray in /home/getagraph/public_html/stock.php on line 1111

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
8473.HK Ex Dividend Knight 2023-08-15 Annually 0 0.00%
2099.HK Ex Dividend Junior 2023-04-19 Annually 0 0.00%
1117.HK Ex Dividend Junior 2023-06-08 Sporadic 0 0.00%
0217.HK Ex Dividend Junior 2023-07-05 Sporadic 0 0.00%
3788.HK Ex Dividend Junior 2023-10-05 Annually 0 0.00%
1696.HK Ex Dividend Junior 2023-08-24 Annually 0 0.00%
0743.HK Ex Dividend Knight 2023-07-07 Annually 0 0.00%
2238.HK Ex Dividend Knight 2023-09-07 Semi-Annually 0 0.00%
1271.HK Ex Dividend Junior 2023-08-10 Semi-Annually 0 0.00%
0336.HK Ex Dividend Junior 2023-09-13 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.07591.5008.4810.00[0 - 0.5]
returnOnAssetsTTM0.01741.2009.4210.00[0 - 0.3]
returnOnEquityTTM0.04261.500-0.638-0.957[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.1490.8009.257.40[1 - 3]
quickRatioTTM0.8850.8009.507.60[0.8 - 2.5]
cashRatioTTM0.3921.5008.9310.00[0.2 - 2]
debtRatioTTM0.375-1.5003.75-5.62[0 - 0.6]
interestCoverageTTM0.8631.000-0.791-0.791[3 - 30]
operatingCashFlowPerShareTTM0.4712.009.8410.00[0 - 30]
freeCashFlowPerShareTTM0.1462.009.9310.00[0 - 20]
debtEquityRatioTTM0.871-1.5006.52-9.78[0 - 2.5]
grossProfitMarginTTM0.6681.0002.192.19[0.2 - 0.8]
operatingProfitMarginTTM0.09101.000-0.180-0.180[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1761.000-0.132-0.132[0.2 - 2]
assetTurnoverTTM0.2290.800-1.804-1.443[0.5 - 2]
Total Score7.51

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM20.931.0007.990[1 - 100]
returnOnEquityTTM0.04262.50-0.410-0.957[0.1 - 1.5]
freeCashFlowPerShareTTM0.1462.009.9510.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.4712.009.8410.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM1.8901.5000.7340[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2881.0005.300[0.1 - 0.5]
Total Score3.34

Luye Pharma Group Ltd

Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers and other solid tumors; and Xuezhikang, a lipid regulating drug for the treatment of hypercholesterolaemia. It also provides Maitongna for cerebral edema swelling by trauma or surgery, and for venous reflux disorders; Beixi, an acarbose capsule for Type 2 diabetes; Rivastigmine Transdermal Patch for the treatment of Alzheimer's disease; Fentanyl Transdermal Patch for cancer pain; Buprenorphine Transdermal Patch for chronic pain; and Seroquel and Seroquel XR for the treatment of schizophrenia and manic episodes of bipolar affective disorders, In addition, the company offers Rykindo, an injection for the treatment of schizophrenia; Tiandixin used as an adjuvant therapy for malignant tumors, hydrothorax and ascites, and respiratory infections; Yitaida for acute promyelocytic leukemia and liver cancer; Lutingnuo, a glutathione injection for toxicity and injuries caused by ionizing radiation; and Beitangning, a pioglitazone hydrochloride capsule to control blood glucose. Further, it offers Nuosen for acute upper digestive tract hemorrhage; Sailimai for the treatment of diarrhea; Apleek Transdermal Patch for contraception; Sidinuo for osteoporosis; Glucosamine hydrochloride tablets for osteoarthritis; Oulai, a compound sodium aescinate gel for local swelling; Oukai for the treatment of soft tissue swelling and venous edema; and Fengshiye for patients who have pains in bones, joints, and limbs. The company distributes and sells pharmaceutical drugs; and manufactures and sells biopharmaceutical products. Luye Pharma Group Ltd. was founded in 1994 and is headquartered in Yantai, the People's Republic of China.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators